He will secure the deals for Zealand Pharma
The latest senior executive to join the management board in Danish biotech company Forward Pharma is going to fill a void created one year ago and help secure deals of all sizes and scopes through his international network.
BY STEFAN SINGH KAILAY
Carlos de Souza’s past is going to help secure a brighter future for Zealand Pharma. He joined the Danish biotech company this month, where he has been put in charge of business development. The new executive brings past experience from the international biopharma industry and leading positions in companies such as Nycomed/Takeda, Pfizer, Novartis, BBB Therapeutics, and Newron Pharmaceuticals – and that experience, among other things, will be brought into play in his role for Zealand.
Allerede abonnent?Log ind her
Læs hele artiklen
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
Med din prøveperiode får du:
Få fuld adgang til dig og dine kollegaer
Start et gratis virksomhedsprøveabonnementRelaterede artikler
Zealand to bet on niche markets
For abonnenter
Billion-dollar deal validates Zealand project
For abonnenter
